Paper34097166
Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.
Rocchi C and 5 others. Dig Dis Sci, 2022. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review. Papers, record 34097166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34097166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colitis, Ulcerative | Major topic |
| Colonic Pouches | Major topic |
| Crohn Disease | Major topic |
| Pouchitis | Major topic |
| Proctocolectomy, Restorative | Major topic |
| Humans | |
| Retrospective Studies | |
| Ustekinumab |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24876789 | Measuring disease activity in Crohn's disease: what is currently available to the clinician. | Clin Exp Gastroenterol | 2014 | https://conductscience.org/library/papers/24876789 | PubMed |
| 2 | 8624195 | Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. | Arch Surg | 1996 | https://conductscience.org/library/papers/8624195 | PubMed |
| 3 | 32199882 | Efficacy of IL12/23 Blockade Expands Our Therapeutic Targets and Challenges the Old Dogma in Ulcerative Colitis. | Gastroenterology | 2020 | https://conductscience.org/library/papers/32199882 | PubMed |
| 4 | 31136680 | Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/31136680 | PubMed |
| 5 | 22875487 | Efficacy of biologic therapy in patients with chronic pouchitis. | Int J Colorectal Dis | 2013 | https://conductscience.org/library/papers/22875487 | PubMed |
| 6 | 29688479 | Ustekinumab Treatment in Crohn's Disease of Barnett Continent Intestinal Reservoir. | Inflamm Bowel Dis | 2018 | https://conductscience.org/library/papers/29688479 | PubMed |
| 7 | 32067061 | Ileal pouch-anal anastomosis in ulcerative colitis: outcomes, functional results, and quality of life in patients with more than 10-year follow-up. | Int J Colorectal Dis | 2020 | https://conductscience.org/library/papers/32067061 | PubMed |
| 8 | 20047579 | Natural history of Crohn's disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis. | Aliment Pharmacol Ther | 2010 | https://conductscience.org/library/papers/20047579 | PubMed |
| 9 | 9351572 | Crohn's-like complications in patients with ulcerative colitis after total proctocolectomy and ileal pouch-anal anastomosis. | Am J Surg Pathol | 1997 | https://conductscience.org/library/papers/9351572 | PubMed |
| 10 | 12072630 | Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up. | Dis Colon Rectum | 2002 | https://conductscience.org/library/papers/12072630 | PubMed |
| 11 | 30810748 | Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort. | Inflamm Bowel Dis | 2019 | https://conductscience.org/library/papers/30810748 | PubMed |
| 12 | 29867171 | Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical Trials. | Am J Gastroenterol | 2018 | https://conductscience.org/library/papers/29867171 | PubMed |
| 13 | 24714229 | The role of antibiotics and probiotics in pouchitis. | Ann Gastroenterol | 2012 | https://conductscience.org/library/papers/24714229 | PubMed |
| 14 | 28008631 | Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. | Aliment Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28008631 | PubMed |
| 15 | 27959607 | Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27959607 | PubMed |
| 16 | 27057684 | Crohn's Disease of the Ileoanal Pouch. | Inflamm Bowel Dis | 2016 | https://conductscience.org/library/papers/27057684 | PubMed |
| 17 | 27751880 | Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases. | Gastroenterology | 2017 | https://conductscience.org/library/papers/27751880 | PubMed |
| 18 | 667572 | Proctocolectomy without ileostomy for ulcerative colitis. | Br Med J | 1978 | https://conductscience.org/library/papers/667572 | PubMed |
| 19 | 20002692 | Outcome and long-term function of restorative proctocolectomy for Crohn's disease: comparison to patients with ulcerative colitis. | Colorectal Dis | 2011 | https://conductscience.org/library/papers/20002692 | PubMed |
| 20 | 29423578 | Effective use of ustekinumab for prepouch ileitis without improvement of concomitant pouchitis. | Tech Coloproctol | 2018 | https://conductscience.org/library/papers/29423578 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41732330 | Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU. | Ther Adv Gastroenterol | 2026 | https://conductscience.org/library/papers/41732330 | PubMed |
| 39897343 | Navigating Chronic Pouchitis: Pathogenesis, Diagnosis, and Management. | Gastroenterol Hepatol (N Y) | 2025 | https://conductscience.org/library/papers/39897343 | PubMed |
| 39600566 | Raising the bar in ulcerative colitis management. | Ther Adv Gastroenterol | 2024 | https://conductscience.org/library/papers/39600566 | PubMed |
| 38664536 | Pouchitis: pathophysiology and management. | Nat Rev Gastroenterol Hepatol | 2024 | https://conductscience.org/library/papers/38664536 | PubMed |
| 38592377 | Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms. | J Clin Med | 2024 | https://conductscience.org/library/papers/38592377 | PubMed |
| 36844648 | Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment. | Curr Treat Options Gastroenterol | 2022 | https://conductscience.org/library/papers/36844648 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL12B | 3593 | PubTator's text mining | https://conductscience.org/library/genes/3593 | NCBI Gene |
| IL23A | 51561 | PubTator's text mining | https://conductscience.org/library/genes/51561 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34097166
GET https://conductscience.org/api/papers/v1/34097166/references?page=2